Finzati - Logo
ZVRA logo

Zevra Therapeutics, Inc.

ZVRA • Biotechnology
$10.47
▲ +0.31 (+3.05%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$642.19M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Stable or improving margins · 78.2%Positive revenue growth · 18.9%Reasonable earnings multiple · 5.95Manageable debt level · 0.41Healthy liquidity · 5.68
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:21 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$10.47
Change3.05%
Shares Out61.34M
Market Cap$642.19M
Enterprise Value$420.62M
52W Range7.16 - 15.04
Beta0.85
P/E11.02
P/S4.72
P/B2.95
P/FCF16.58
EV/Sales3.09

Investment DNA

How strong this company looks for long-term investors

68
out of 100
Business Quality
Margins, moat, returns
65/100
Financial Strength
Debt, cash, stability
75/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
83/100
Why this score▼
Stable or improving margins · 78.2%Positive revenue growth · 18.9%Reasonable earnings multiple · 5.95Manageable debt level · 0.41Healthy liquidity · 5.68

Analyst view

Analyst sentiment and price target

ZVRA
Analyst sentiment
Based on 10 analyst votes · 2026-10-21
100/100
Bullish
Bullish
10
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$20.00
Mean
$25.75
Median
$24.00
High
$35.00

Company Overview

IPO: 4/16/2015
Industry: Biotechnology
P/B i: 2.95
Debt / Equity i: 0.41
Operating Margin: -3.98%
Net Margin: 78.17%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.41
Current Ratio: 5.68
Quick Ratio: 5.63
Status: Good

Insider Transactions

Recent executive and insider activity

Thompson Rahsaan
Transaction: 06/22/2026
SELL
Change
-34,557
Price
$12.68
Filing
06/23/2026
Type
SELL
Thompson Rahsaan
Transaction: 06/21/2026
SELL
Change
-66,667
Price
Not reported
Filing
06/23/2026
Type
SELL
Thompson Rahsaan
Transaction: 06/21/2026
BUY
Change
+66,667
Price
Not reported
Filing
06/23/2026
Type
BUY